Current Drug Targets

Papers
(The H4-Index of Current Drug Targets is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Cell Entry and Unusual Replication of SARS-CoV-244
SARS-Coronavirus 2, A Metabolic Reprogrammer: A Review in the Context of the Possible Therapeutic Strategies41
The Marburg Virus Outbreak in West Africa37
Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment35
Review on the Drug Intolerance and Vaccine Development for the Leishmaniasis35
The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review34
Current Research Trends in Cytokine Storm: A Scientometric Study33
Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges33
Metformin: A Promising Antidiabetic Medication for Cancer Treatment32
Possible Applications of Azurin, a Copper-Containing Protein, in Cancer Treatment: Prospects and Challenges30
Meet the Regional Editor29
Betaine, a Potential Therapeutic Alternative for the Treatment of Depression28
Xerostomia: Advances and Challenges in Drug Development26
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery25
Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach24
Targeted Delivery Strategies of Herbal-Based Nanogels: Advancements and Applications24
Bile Acid Application in Cell-Targeting for Molecular Receptors in Relation to Hearing: A Comprehensive Review23
Targeting Neurodegeneration: The Emerging Role of Hybrid Drugs23
COVID-19 Induces Cytokine Storm and Dysfunctional Hemostasis23
Exploring the Potential Molecular Mechanisms of Berberine against Gastric Cancer Liver Metastasis Based on Network Pharmacology and Bioinformatics23
An Updated Insight into Phytomolecules and Novel Approaches used in the Management of Breast Cancer22
Targets Involved in the Pharmacology of Bothrops Snakebite: Statu Quo and Future Perspectives21
Investigating Alternative Treatments for Dyslipidemia Using Bioactive Compounds Derived from Kiwifruit (Actinidia chinensis): A Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulati21
0.16522789001465